AbCellera Biologics Inc (NAS:ABCL)
$ 8.01 -0.10 (-1.23%) Market Cap: 2.40 Bil Enterprise Value: 2.08 Bil PE Ratio: 0 PB Ratio: 2.59 GF Score: 56/100

AbCellera Biologics Inc (ABCL) Transcripts

  • 1